Myostatin serum levels in children with type 1 diabetes mellitus
- 6 September 2021
- journal article
- research article
- Published by Springer Nature in Hormones
- Vol. 20 (4) , 777-782
Abstract
Purpose Type 1 diabetes mellitus (T1DM) can cause several complications, among them myopathy, which can appear even in adolescents. This is of importance, since skeletal muscle is the largest of the insulin-sensitive tissues and thus plays a significant role in glucose homeostasis. A prime regulator of skeletal muscle mass is myostatin, a protein which has a negative role in skeletal muscle development but also in glucose homeostasis, causing insulin resistance. Since myopathy is a complication of T1DM and myostatin is a fundamental regulator of skeletal muscle and is also involved in glucose homeostasis, we investigated the serum levels of myostatin in children with T1DM. Methods We determined myostatin serum levels using ELISA in 87 children with T1DM aged 10.62 ± 3.94 years, and in 75 healthy children aged 10.46 ± 3.32 years old. Results Myοstatin was significantly elevated in T1DM compared to the healthy control children (23.60 ± 7.70 vs 16.74 ± 6.95 ng/ml, p < 0.0001). Myostatin was not correlated with body mass index (BMI) SD or hemoglobin A1c (HbA1c). Conclusion Children with T1DM have significantly higher serum levels of myostatin compared to healthy children of the same age and BMI SD. The elevated myostatin in T1DM could reflect impaired muscle function and/or glucose metabolism, or could represent a homeostatic mechanism.Keywords
This publication has 41 references indexed in Scilit:
- Plasma and Muscle Myostatin in Relation to Type 2 DiabetesPLOS ONE, 2012
- Investigation of Myostatin Serum Levels Before and After a 6-Month Lifestyle Intervention Program in Obese ChildrenExperimental and Clinical Endocrinology & Diabetes, 2010
- Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 DiabetesDiabetes, 2010
- Insulin Resistance in Adolescents with Type 1 Diabetes and Its Relationship to Cardiovascular FunctionThe Journal of Clinical Endocrinology & Metabolism, 2010
- Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin SensitivityPLOS ONE, 2009
- Loss-of-Function Mutation in Myostatin Reduces Tumor Necrosis Factor α Production and Protects Liver Against Obesity-Induced Insulin ResistanceDiabetes, 2009
- Increased Secretion and Expression of Myostatin in Skeletal Muscle From Extremely Obese WomenDiabetes, 2009
- Decreased isometric muscle strength after acute hyperglycaemia in Type 1 diabetic patientsDiabetic Medicine, 2005
- Natural Course of Insulin Resistance in Type I DiabetesNew England Journal of Medicine, 1986
- Impaired Insulin Action in PubertyNew England Journal of Medicine, 1986